NEDD9, an independent good prognostic factor in intermediate-risk acute myeloid leukemia patients - Pallarès, Victor (Institut d'Investigació Biomèdica Sant Pau) ; Hoyos, Montserrat (Institut d'Investigació Biomèdica Sant Pau) ; Chillón, M. Carmen (CIBER in Oncology (CIBER-ONC), Madrid, Spain) ; Barragán, Eva (CIBER in Oncology (CIBER-ONC), Madrid, Spain) ; Conde, M. Isabel Prieto (Department of Hematology, University Hospital of Salamanca and Center of Investigation in Cancer-IBMCC, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain) ; Llop, Marta (Clinical Laboratory and Department of Hematology, University Hospital La Fe, Valencia, Spain) ; Céspedes, María Virtudes (CIBER en Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Barcelona, Spain) ; Nomdedeu, Josep F. (Institut d'Investigació Biomèdica Sant Pau) ; Brunet, Salut (Institut d'Investigació Biomèdica Sant Pau) ; Sanz, Miguel Ángel (CIBER in Oncology (CIBER-ONC), Madrid, Spain) ; González-Díaz, Marcos (CIBER in Oncology (CIBER-ONC), Madrid, Spain) ; Sierra, Jorge (Universitat Autònoma de Barcelona, Barcelona, Spain) ; Casanova, Isolda (Josep Carreras Leukemia Research Institute, Barcelona, Spain) ; Mangues, Ramon (Josep Carreras Leukemia Research Institute, Barcelona, Spain)
 
Comments (0) | Reviews (0)
Start a discussion about any aspect of this document.

 Subscribe to this discussion. You will then receive all new comments by email.

Add comment


Once logged in, authorized users can also attach files.
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.
          You can use some HTML tags: <a href>, <strong>, <blockquote>, <br />, <p>, <em>, <ul>, <li>, <b>, <i>